识别广泛保存的寄生性线虫蛋白,激活免疫力
Bruce A Rosa1, Dante S Zarlenga2, Valsin M Fournet2
1Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, MO, United States.
Frontiers in parasitology
|January 16, 2025
概括
开发一种寄生性线虫疫苗是具有挑战性的,因为免疫逃避. 这项研究使用了基因组学/蛋白质学方法来识别潜在的疫苗抗原,为未来的寄生性线虫疫苗开发创造了宝贵的资源.
科学领域:
- 兽医免疫学 兽医免疫学
- 寄生虫学的寄生虫学
- 基因组学和蛋白质组学
背景情况:
- 土壤传播的线虫对人类健康和农业构成重大威胁.
- 现有的甲虫疗法面临着一些挑战,包括效率低下,耐药性和持久性感染阶段.
- 寄生性线虫通常会诱导一种非保护性的Th2免疫反应,并且已经进化了逃避宿主免疫力的机制,阻碍了疫苗的开发.
研究的目的:
- 为了识别来自胃肠道 (GI) 寄生虫线虫的保存和特定物种免疫性分泌/分泌 (E/S) 蛋白质.
- 开发一种使用重组蛋白质尾酒的疫苗策略,以向保存的肠道线虫抗原.
- 创建一个全面的数据库,用于识别各种寄生性线虫中的目标蛋白.
主要方法:
- 采用了基因组学/蛋白质学方法,包括对感染*Trichuris suis*的猪进行免疫块实验.
- 用五种重组蛋白质的尾酒来免疫猪,并在血清和肠液中分析了抗体反应.
- 使用生物信息学,实验和基于文献的同源寄生虫蛋白质优先排序,构建了一个抗体-蛋白质阵列.
主要成果:
- 对抗体-蛋白质阵列的选表明同类蛋白质之间的交叉反应性和一般免疫激活.
- 主要成分分析 (PCA) 聚类揭示了免疫接种后总体免疫反应的变化.
- 在*Ascaris suum*或*Trichuris suis*直接挑战后,没有观察到免疫反应的实质性变化.
结论:
- 引起免疫激活的蛋白质是疫苗开发的有希望的候选者.
- 开发的多omics数据库是识别各种寄生虫线虫中的标蛋白质的关键资源.
- 一个计算,比较的基因组学/蛋白质组学策略是强烈支持开发有效的寄生虫线虫疫苗.
相关概念视频
Immune Response Against Viral Pathogens
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Amebiasis
Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...


